bluuebunny/crossref_metadata_2025_split huggingface dataset:
Pengaruh Positive Self-talk: Intervensi Melalui Audio-Visual Terhadap Tingkat Kecemasan Remaja
Authors: Putri Widya Kurnia , Guna Stephanie Dwi , Rustam Musfardi 
Published: December 2024

Masa remaja merupakan fase dimana perubahan masa kanak-kanak menuju dewasa. Salah satu faktor yang menyebabkan kecemasan pada remaja adalah kecemasan yang dipicu oleh ketidakyakinan akan kemampuan diri untuk mengatasi tugas-tugas akademik. Positive self-talk adalah intervensi dengan cara berdialog dengan diri sendiri menggunakan kalimat positif yang efektif untuk menurunkan kecemasan. Penelitian ini bertujuan untuk mengetahui Pengaruh Positive Self-talk: Intervensi Melalui Audio-Visual terhadap Tingkat Kecemasan pada remaja di MAN 1 Pekanbaru. Penelitian ini menggunakan metode quasy experiment diambil dengan menggunakan purposive sampling dengan desain pretest-posttest with control group. Positive self-talk diberikan melalui audiovisual. Sampel penelitian berjumlah 32 orang yang terbagi menjadi 16 orang kelompok eksperimen dan 16 orang kelompok kontrol. Alat ukur penelitian yang digunakan adalah HARS untuk mengukur tingkat kecemasan. Analisis yang digunakan adalah analisis univariat dan bivariat dengan menggunakan Uji Dependent T Test dan Uji Independent Sample T Test. Rata-rata tingkat kecemasan remaja setelah diberikan intervensi adalah 17,38 dan pada kelompok kontrol yang tidak diberikan intervensi adalah 21,94. Hasil Uji Independent T Test diperoleh nilai P (0,004) dan hasil Dependent T test p (0,000). Positive Self-talk efektif menurunkan tingkat kecemasan pada remaja yang mengalami kecemasan akademik.
Cytotoxic activity of phenolic compounds in Bairui Granules obtained from the Chinese medicinal plant Thesium chinense
Authors: Zhang Shaobin , Chen Hong , Hua Juan , Luo Shihong 
Published: December 2024

The Chinese medicinal plant Thesium chinense Turcz. is the only plant used in the manufacture of Bairui Granules. However, to date, there has been very little research into the cytotoxic activity of active substances derived from Bairui Granules. Using chemical separation and spectroscopic methods, phenolic compounds 1–5 were identified as methyl-p-hydroxycinnamate, vanillin, kaempferol, isorhamnetin-3-O-glucoside, and astragalin, respectively. UPLC-MS/MS analyses revealed that compounds 1–5 were present at concentrations of 0.006 ± 0.002, 1.63 ± 0.87, 3.65 ± 0.83, 26.97 ± 11.41, and 27.67 ± 2.91 μg/g, respectively in Bairui Granules. Compounds 1, 2, and 4 were detected here for the first time in Bairui Granules. Using co-culture experiments, isorhamnetin-3-O-glucoside (4) was found to be beneficial to the proliferation Chinese hamster ovary (CHO) cells (6.46% ± 0.86% to 38.45% ± 9.04%), natural killer cells from human umbilical cord blood (UCB NK cells) (25.68% ± 0.02% to 70.81% ± 0.26%), and mesenchymal stem cells from human umbilical cord blood (UCB MSC cells) (1.66% ± 0.05% to 27.64% ± 0.51%) when the concentration was similar to that found in Bairui granules. Moreover, vanillin (2) was conducive to UCB NK cells proliferation (28.21% ± 0.44%) at a concentration of 64 μg/mL, while maintaining cell viability. UCB NK cell proliferation was promoted at rates of 41.03% ± 0.48% to 67.22% ± 0.68% when astragalin (5) was present at low concentrations (8 and 16 μg/mL). Methyl-p-hydroxycinnamate (1) and vanillin (2) at different concentrations both had an inhibitory effect on the proliferation of natural killer cells from human peripheral blood (PB NK cells), but the inhibitory concentration ranges of these compounds were not equivalent to the concentration ranges of the compounds in Bairui Granules. These results provide a foundation for the safe use of T. chinense preparations.
Two mixed-valent cerium oxo clusters: synthesis, structure, and self-assembly
Authors: Gao Yuan , Zhang Yang , Han Zhe , Wang Chunhui , Zhang Lei , Qiu Jie 
Published: December 2024

Studies on cerium oxo clusters (CeOCs) are not only significant for understanding the redox and hydrolysis behaviors of Ce(III/IV) ions but also crucial for the rational synthesis of novel clusters and nanoceria with specific Ce(III)/Ce(IV) ratios. Here, two sets of reactions were conducted using cerium nitrate and H2O2-oxidized cerium nitrate, resulting in the formation of two distinct mixed-valent CeOCs [CeIII4CeIV10O14(OH)2(PhCO2)22(DMF)6] (Ce14) and [CeIII2CeIV22O28(OH)8(PhCO2)30(DMF)4] (Ce24C). These two clusters exhibit different structures and Ce(III)/Ce(IV) ratios, demonstrating the critical role of cerium oxidation states and the occurrence of redox reactions in cluster formation. Ce14 is the first tetradecanuclear CeOC with a novel structure, whereas Ce24C differed in its Ce(III)/Ce(IV) ratio, protonation levels of O atoms, and ligands from previously reported 24-nuclear CeOCs. Furthermore, various techniques were employed to investigate the formation process of these two clusters. X-ray photoelectron spectra (XPS) revealed that the white precipitates formed during the preparation of Ce14 contain Ce(III) ions, while the reddish-brown precipitates formed during the preparation of Ce24C contain a mixture of Ce(III) and Ce(IV) ions. These two precipitations were individually dissolved in N,N-Dimethylformamide (DMF). The evolution of solution color and ultraviolet-visible (UV-Vis) spectra over time revealed the gradual oxidation of partial Ce(III) ions by oxygen in the solution of the white precipitation. As Ce(IV) ions increased in this solution, time-resolved small angle X-ray scattering (SAXS) data demonstrated the self-assembly of the Ce14 clusters after 4 days. In contrast, SAXS data and UV-Vis spectra revealed the rapid assembly of Ce24C clusters within 2 h due to the initial coexistence of Ce(IV) and Ce(III) ions in the DMF solution of the reddish-brown precipitation. The continued reduction of partial Ce(IV) ions in this solution does not affect Ce24C clusters’ formation and stability. Our studies expand the family of CeOCs and enhance our understanding of the effects of cerium’s oxidation states on cluster formation.
Spatial transcriptomics and in situ immune cell profiling of the host ectocervical landscape of HIV infected Kenyan sex working women
Authors: Franzén Boger Mathias , Kaldhusdal Vilde , Pascual-Reguant Anna , Kroh Sandy , Uecker Ralf , Burgener Adam D. , Lajoie Julie , Omollo Kenneth , Kimani Joshua , Fowke Keith R. , Hauser Anja E. , Tjernlund Annelie , Broliden Kristina 
Published: December 2024

IntroductionChronic immune activation is a hallmark of human immunodeficiency virus (HIV) infection that significantly impacts disease pathogenesis. However, in-depth studies characterizing the immunological landscape of the ectocervix during chronic HIV infection remain scarce despite the importance of this tissue site for HIV transmission.MethodsEctocervical tissue samples were obtained from antiretroviral-naïve HIV-seropositive and -seronegative Kenyan female sex workers. These samples were assessed by spatial transcriptomics and Gene Set Enrichment Analysis. We further performed multi-epitope ligand cartography (MELC) using an in situ staining panel that included 17 markers of primarily T cell–mediated immune responses.ResultsSpatial transcriptomics revealed tissue-wide immune activation encompassing immune responses associated with chronic HIV infection. First, both the epithelial and submucosal compartments showed diverse but significant upregulation of humoral immune responses, as indicated by the expression of several antibody-related genes. Second, an antiviral state–associated cellular immunity was also observed in the HIV-seropositive group, characterized by upregulation of genes involved in interferon signaling across the mucosal tissue and a more spatially restricted mucosal expression of genes related to T cell activity and effector functions relative to the HIV-seronegative group. Additionally, HIV associated structural alterations were evident within both compartments. Downregulated genes across the epithelium were mainly linked to epithelial integrity, with the outer layer involved in terminal differentiation and the inner layer associated with epithelial structure. MELC analysis further revealed a significantly increased ectocervical leukocyte population in HIV-seropositive participants, primarily driven by an increase in CD8+ T cells while the CD4+ T cell population remained stable. Consistent with our spatial transcriptomics data, T cells from HIV-seropositive participants showed an increased effector phenotype, defined by elevated expression of various granzymes.ConclusionBy combining spatial transcriptomics and MELC, we identified significant HIV-associated cervical immune activity driven by induction of both T and B cell activity, together with a general antiviral state characterized by sustained interferon induction. These findings underscore that chronic HIV infection is associated with an altered ectocervical mucosal immune landscape years after primary infection. This sheds light on HIV pathogenesis at distant local sites and complements current knowledge on HIV-associated systemic immune activation.
Prognostic model based on disulfidptosis-related lncRNAs for predicting survival and therapeutic response in bladder cancer
Authors: Han Lirui , Yang Hankai , Jiang Xuan , Zhou Ziyu , Ge Chang , Yu Kairan , Li Guofang , Wang Wei , Liu Yubo 
Published: December 2024

BackgroundWith poor treatment outcomes and prognosis, bladder cancer remains a focus for clinical research in the precision oncology era. However, the potential of disulfidptosis, a novel cell death mechanism, and its related long non-coding RNAs to support selective cancer cell killing in this disease is still unclear.MethodsWe identified key disulfidptosis-related lncRNAs in bladder cancer, constructed a prognostic risk model with potential therapeutic targets, and confirmed the findings through quantitative PCR analysis.ResultsWe identified five crucial lncRNAs (AC005840.4, AC010331.1, AL021707.6, MIR4435-2HG and ARHGAP5-AS1) and integrated them into a predictive model centered on disulfidptosis-associated lncRNAs. Reliability and validity tests demonstrated that the lncRNA prediction index associated with disulfidptosis effectively discerns patients’ prognosis outcomes. Additionally, high-risk patients exhibited elevated expression levels of genes involved in the PI3K-Akt signaling pathway, extracellular matrix organization, and immune escape mechanisms, which are associated with poor prognosis. Notably, high-risk patients demonstrated higher sensitivity to Sorafenib, Oxaliplatin and MK-2206, underscoring the promise of these lncRNAs as precise therapeutic targets in bladder cancer.ConclusionBy revealing the predictive importance of disulfidptosis-associated lncRNAs in bladder cancer, our research offers new perspectives and pinpoints potential therapeutic targets in clinical environments.
Extracranial arteriovenous malformations: a 10-year experience at a German vascular anomaly center and evaluation of diagnostic imaging for endovascular therapy assessment
Authors: Werba Nadja , Ludwig Johannes , Weiss Christel , Struebing Felix , Schoenberg Stefan , Sadick Maliha 
Published: December 2024

BackgroundArteriovenous malformations (AVMs) account for &lt;3% of vascular anomalies. This study aims to present the 10-year experience of a German vascular anomaly center (VAC) with AVMs and evaluate diagnostic imaging for treatment-relevant information for minimally invasive therapy planning.Material and methodsA retrospective study including patients from the VAC database with AVMs was conducted. Clinical information from patients' records was evaluated. An additional image reading analysis of the available diagnostic imaging using a 4-point Likert scale, focusing on relevant points for minimally invasive treatment planning, was conducted in 13 patients who had all three magnetic resonance tomography (MRI), computed tomography (CT), and conventional angiography available.ResultsBetween April 2014 and March 2024, 60 patients (60% female, 40% male; 12% Parkes Weber syndrome) with AVMs presented to the VAC. The median age was 36 years (range: 11–78 years). Referral diagnosis was correct in 73.3% of cases. The mean distance to the VAC was 102.5 km (±111.0). The most common locations involved the hand (32%), lower extremity (22%), and pelvis (22%). The most common symptoms were pain (81%), pulsation (64%), and local hyperthermia (62%). Necrosis was significantly more common when the AVM was located in the hand (p = 0.0129) and growth when located in the pelvis (p = 0.0037). Furthermore, cosmetic issues were significantly more frequent when the AVM was located in the head area (p = 0.0333). Most patients presented with Schobinger stage II (57%). Right heart strain was only documented in one case. A total of 47% had undergone invasive therapies before VAC admission. In 30% of cases, further minimally invasive or invasive therapy was required. In the diagnostic imaging evaluation, conventional angiography had the overall best ratings for image quality (median = 1.00; range: 1.00–2.00), NIDUS evaluation median = 1.00; range: 1.00–2.00), and therapy planning (median = 1.00; range: 1.00–1.33).ConclusionOur 10-year experience showed that in patients with AVMs, the correct diagnosis is often made before admission to a specialized VAC. Diagnostic imaging is essential for endovascular treatment planning, with conventional angiography showing superior utility in image quality, NIDUS evaluation, and therapy planning compared to other modalities.
Computer-aided endoscopic diagnostic system modified with hyperspectral imaging for the classification of esophageal neoplasms
Authors: Wang Yao-Kuang , Karmakar Riya , Mukundan Arvind , Men Ting-Chun , Tsao Yu-Ming , Lu Song-Cun , Wu I-Chen , Wang Hsiang-Chen 
Published: December 2024

IntroductionThe early detection of esophageal cancer is crucial to enhancing patient survival rates, and endoscopy remains the gold standard for identifying esophageal neoplasms. Despite this fact, accurately diagnosing superficial esophageal neoplasms poses a challenge, even for seasoned endoscopists. Recent advancements in computer-aided diagnostic systems, empowered by artificial intelligence (AI), have shown promising results in elevating the diagnostic precision for early-stage esophageal cancer.MethodsIn this study, we expanded upon traditional red–green–blue (RGB) imaging by integrating the YOLO neural network algorithm with hyperspectral imaging (HSI) to evaluate the diagnostic efficacy of this innovative AI system for superficial esophageal neoplasms. A total of 1836 endoscopic images were utilized for model training, which included 858 white-light imaging (WLI) and 978 narrow-band imaging (NBI) samples. These images were categorized into three groups, namely, normal esophagus, esophageal squamous dysplasia, and esophageal squamous cell carcinoma (SCC).ResultsAn additional set comprising 257 WLI and 267 NBI images served as the validation dataset to assess diagnostic accuracy. Within the RGB dataset, the diagnostic accuracies of the WLI and NBI systems for classifying images into normal, dysplasia, and SCC categories were 0.83 and 0.82, respectively. Conversely, the HSI dataset yielded higher diagnostic accuracies for the WLI and NBI systems, with scores of 0.90 and 0.89, respectively.ConclusionThe HSI dataset outperformed the RGB dataset, demonstrating an overall diagnostic accuracy improvement of 8%. Our findings underscored the advantageous impact of incorporating the HSI dataset in model training. Furthermore, the application of HSI in AI-driven image recognition algorithms significantly enhanced the diagnostic accuracy for early esophageal cancer.
The use of nutrigenomics and nutritional biomarkers with standard care of long-term recurrent metastatic rectal cancer: a case report
Authors: Brinkman Maree T. , Crofts Sam , Green Hayden 
Published: December 2024

IntroductionDistant metastases following standard treatment for locally advanced rectal cancer (LARC) are typically associated with poor disease-free survival. We report on a 52-year-old Australian male of Dutch ancestry with no family history of colorectal cancer or significant medical history who experienced bleeding per rectum for several months prior to a colonoscopy in July 2010. He was subsequently diagnosed with Stage IIb LARC.Case presentationDespite treatment with curative intent, a distant recurrence to his left lung was detected in May 2012, upstaging him to Stage IV rectal cancer. He had repeated distant metastatic recurrences over the next 8 years, and treatment included multiple surgeries, chemotherapies, radiation treatments, a “watch and wait” period of 20 months, and personalised dietary management. Genetic and nutrigenomic testing identified that the case had KRAS and MTHFR mutations. As part of his dietary management, the case also had his levels of folate, vitamin B12, and vitamin D regularly monitored because of his genetic predisposition and history of deficiency for these key nutrients. Apart from changes in his CEA levels, sudden increases in the patient’s folate levels, inconsistent with dietary exposures preceded detection of each new distant recurrence, with significant decreases in the levels at the next follow-up measurement.ConclusionA multimodal approach to this patient’s management appeared to contribute to his long-term survival of nearly 10 years from the initial diagnosis. Multidisciplinary management, including the use of additional biomarkers, may enhance survival rates in other similar cases with advanced disease resistant to differing therapies, and with potentially poor prognosis.
Sorafenib combined with tarexib for first-line treatment of unresectable hepatocellular carcinoma and its predictive role and correlation with PD-L1 CTCs
Authors: Xu Lin , Che Xu 
Published: December 2024

BackgroundThis study aims to evaluate the safety efficacy of combining the PD-1 antibody Tirelizumab with Sorafenib in the treatment of advanced hepatocellular carcinoma. Additionally we are committed to investigating the relationship between circulating tumor cell (CTC) counts/PD-L1 expression the prognosis of patients with advanced hepatocellular carcinoma.MethodsThis study included 32 patients with unresectable primary liver cancer who received treatment with Tislelizumab in combination with Sorafenib. Tislelizumab was administered via intravenous injection at a dose of 200 mg every 3 weeks, while Sorafenib was given orally at a dose of 400 mg twice daily. Patients were evaluated every 3 cycles (9 weeks) to assess the safety and efficacy of the treatment regimen. Prior to enrollment, all patients underwent CTC counting and assessment of PD-L1 expression in circulating tumor cells. The primary endpoint was the objective response rate (ORR), evaluated by the investigator according to the RECIST v1.1 criteria. Secondary endpoints aimed to assess the relationship between circulating tumor cell (CTC) counts or programmed death ligand 1 (PD-L1) expression and the prognosis of patients with advanced hepatocellular carcinoma.ResultsAs of November 2022, a total of 32 patients have been enrolled in the study and received combination treatment. Among the 32 patients, 31 (96.8%) tested positive for circulating tumor cells (CTCs), with counts ranging from 1 to 45 and a median of 7 (3, 11). PD-L1-positive CTCs were detected in 25 patients (78.1%). All 32 patients were followed up for 2 to 14 months, with a median follow-up time of 6 months. Correlation analysis revealed that distant metastasis, vascular invasion, and the presence of more than 5 CTCs were significantly associated with PD-L1-positive CTCs. The one-year overall survival rates for patients with PD-L1-positive CTCs and those with PD-L1-negative CTCs were 78.5% vs 64.3% (P = 0.309). Additionally, the one-year overall survival rates for the group with rising CTC counts compared to the group with stable or declining counts were 34.3% vs 90% (P = 0.063).ConclusionThe combination of Tislelizumab and Sorafenib demonstrates promising antitumor activity in the first-line treatment of hepatocellular carcinoma, with a relatively high objective response rate (ORR) and acceptable safety profile. Baseline CTC PD-L1 positivity can serve as a predictive marker for selecting hepatocellular carcinoma patients for PD-1/PD-L1 blockade therapy, and dynamic measurement of CTC changes can be used to monitor treatment efficacy.
Nephrocalcinosis tendency does not worsen under burosumab treatment for X-linked hypophosphatemic rickets: a multicenter pediatric study
Authors: Levi Shelly , Landau Daniel , Davidovits Miriam , Shapira Rootman Mika , Brener Avivit , Gal Shoshana , Borovitz Yael , Goldberg Ori , Bello Rachel , Cleper Roxana , Lebenthal Yael , Levy-Shraga Yael , Tiosano Dov , Chezana Adi , Regev Ravit , Zeitlin Leonid 
Published: December 2024

BackgroundX-linked hypophosphatemic rickets (XLH) is associated with uninhibited FGF23 activity, which leads to phosphaturia, hypophosphatemia and depressed active vitamin D (1,25OH2D) levels. Conventional treatment with phosphate supplements and vitamin D analogs may lead to hypercalciuria (HC), nephrocalcinosis (NC) and hyperparathyroidism. We investigated the effects of burosumab treatment, an anti-FGF23 monoclonal antibody recently approved for XLH, on these complications.MethodsThis retrospective study included children with XLH who were treated with burosumab for at least one year at one of three referral centers. Clinical and biochemical potential treatment outcomes were regularly followed, including multiple urine calcium measurements and NC severity score (0 = no NC, 3 = worse NC).ResultsTwenty-six (13 male) children aged 7.6 ± 3.9 years were followed for 27.5 ± 9.6 months. Mean serum phosphate levels rapidly increased from 2.67 ± 0.61 at baseline to 3.57 ± 0.53 mg/dL after 3 months (p &lt; 0.001) and remained stable thereafter. Concomitant decreases were observed in phosphaturia, serum alkaline phosphatase and parathyroid hormone. HC (U-Ca/Cr &gt; 0.2 mg/mg) was detected in 2/26 (7.7%) patients before burosumab initiation, resolved in one and persisted, albeit improved, in the second. Two patients were newly diagnosed with HC, 15 and 3 months after therapy, which persisted in one of them despite dose reduction attempts. Seven patients had NC at baseline (mean score: 1.8 ± 0.34), but none showed deterioration or developed new NC.ConclusionIn children with XLH treated with burosumab, HC was an infrequent side effect and preexisting NC did not worsen.